Schering-Plough lands quartet of Bayer drugs
301955
Fred Hassan has launched his biggest and most ambitious move to rebuild struggling Schering- Plough. The Kenilworth company and German drug maker Bayer yesterday announced an alliance that
575085
NEW YORK/FRANKFURT  - A drug being developed by  Bayer AG and Onyx Pharmaceuticals Inc. shrank tumors in some  liver cancer patients and temporarily stabilized the disease in  others in a small clinical trial, the companies said on  Wednesday.
77782
Schering-Plough Corp  on Monday reported third-quarter profit and sales that fell short of Wall Street's target, sending shares down more than 10 percent amid concerns about its flagship cholesterol drugs.
338909
Germany&#39;s Bayer has agreed to sell its blood products business to US investment firms Cerberus and Ampersand Ventures for about $590 million as it continues to narrow the focus of its health-care business.
691450
BERLIN -- German chemical and drug maker Bayer AG and New Jersey pharmaceutical company Schering-Plough Corp. announced Monday they have entered a strategic alliance under which Schering-Plough will distribute
434669
German chemical and drug maker Bayer AG and New Jersey pharmaceutical company Schering-Plough Corp. announced an alliance Monday under which Schering-Plough will distribute Bayer's primary care pharmaceutical products in the United States.
594500
Schering-Plough Corp. SGP.N on  Thursday reported a quarterly profit after a year-ago loss, as  positive foreign exchange trends helped offset poor sales of  its allergy and hepatitis drugs.
170214
BERLIN - Bayer AG, the German drug and chemical company, has agreed to sell its plasma products business for $590 million in cash and stock to the private US investment groups Cerberus Capital Management and Ampersand Ventures.
71950
Schering-Plough Corp  has agreed to buy Akzo Nobel NV's  drugs unit Organon BioSciences for 11 billion euros ($14.4 billion) in a bid to gain scale and diversify away from cholesterol medicine.
503451
Lanxess AG, the spun-off chemicals and polymers business of German drug maker Bayer AG, made its debut on the Frankfurt stock exchange today.
727152
New developments are brewing at the pharmaceutical.
738382
The drug maker is poised to speed past its rivals.
75799
Schering-Plough and Merck posted strong sales from their joint venture in cholesterol drugs, but otherwise their third-quarter earnings were notably different.
303789
Schering-Plough and Bayer have announced an agreement under which New Jersey-based Schering will attain US marketing rights to Bayer HealthCareâs primary care pharmaceutical products, including the antibiotics Avelox (moxifloxacin HCL) and Cipro
207285
Pfizer Inc. PFE.N has signed a deal  with Schering AG SCHG.DE granting it a worldwide license to  Schering's ADP receptor antagonist program, the U.S. drug maker  said on Wednesday.
725625
German chemicals and pharmaceuticals giant Bayer says it is still open to further acquisitions even though it was still in the process of integrating Berlin-based drug maker Schering which it recently acquired for close to 17 billion euros (22 billion dollars).
633530
Schering-Plough Corp.  is  seriously considering approaching Bristol-Myers Squibb Co.   about a possible merger, according to a report in The  Star-Ledger newspaper on Friday.